Products
BioEngine has developed nearly 100 types of serum-free media for different cell lines, which are suitable for antibodies, vaccines and cell and gene therapy (CGT) fields.
Time:Nov 09,2017
On November 9, 2017, Mr. Gerard Berghahn, Technical Director of Process Equipment of Belfinger Life Science from Salzburg, and his delegation visited BioEngine for exchange. General Manager Yi Lu, Vice General Manager Keyu Shi, and R&D Director Li Fan expressed a warm welcome and had a meeting with them.
At the meeting, Vice President Keyu Shi first introduced the company's technical advantages and business model to the guests. After that, Mr. Berghahnmann gave a detailed introduction to Belfinger's bioreactor online real-time monitoring and control system (Process Analytical Technology (PAT) Soft Sensing). Both sides had an in-depth exchange and discussion on various technical details and future multi-faceted cooperation.
We have a professional technical team to provide high quality one-stop cell culture service from process development
and optimization, medium formulation design to medium processing and manufacturing for all biopharmaceutical companies.
If you have any question, please click "Quick Message" and leave your message, we will reply to you as soon as possible.
If anything urgent, please call (86)21-68582660-2792.
3F&4F, Building 3, Lane 396, Lvzhou Ring Road, Minhang District, Shanghai, PRC